サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1608796

薬理遺伝学検査の世界市場レポート 2024年

Pharmacogenetic Testing Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
薬理遺伝学検査の世界市場レポート 2024年
出版日: 2024年12月09日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

薬理遺伝学検査市場規模は、今後数年で急成長が見込まれます。2028年には222億8,000万米ドルに成長し、CAGRは15.9％となります。予測期間中に予想される成長は、バイオテクノロジーと医療における研究開発の増加、医療費の増加、慢性疾患の蔓延、医療サービスへのアクセス向上、遠隔医療とデジタルヘルスソリューションの台頭など、いくつかの要因に起因しています。この期間を形成すると予想される主要動向には、薬理遺伝学検査の拡大、ゲノム技術の発展、継続的な技術革新、コンパニオン診断の改善、新規診断検査の開発などがあります。

個別化医療に対する需要の高まりは、当面の薬理遺伝学検査市場の成長を牽引すると予想されます。精密医療とも呼ばれる個別化医療は、患者一人ひとりの特性に合わせて医療上の意思決定や治療をカスタマイズする医療アプローチです。個別化医療への注目が高まる背景には、治療成績の向上、予防や早期発見の重視、費用対効果の向上など、複数の要因が影響しています。薬理遺伝学検査は、個人の遺伝的体質を調べ、特定の薬に対する反応を予測することで、個別化医療において重要な役割を果たしています。これにより、医療プロバイダーは遺伝的要因に基づいて治療をカスタマイズし、薬効を最適化し、副作用を最小限に抑えることができます。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、FDAが希少疾患患者向けに新規の個別化治療を2022年の6件から2023年には16件承認したと報告しました。このように、個別化医療に対する需要の高まりが薬理遺伝学検査市場の成長を後押ししています。

薬理遺伝学検査セグメントの主要企業は、配合箋ベースの薬理遺伝学検査のような最先端の薬理遺伝学検査サービスを提供することで、競合を確立しようとしています。配合箋による薬理遺伝学検査は、医療プロバイダーが患者の遺伝子プロファイルを分析するために、薬の配合に先立って特別に注文または配合する遺伝子検査です。例えば、2023年5月、米国の医療機関であるUCSFは、治療の精度を高めることを目的としたファーマコゲノミクス検査サービスを導入しました。このサービスは、医療提供者が個人の遺伝子プロファイルに従って薬剤療法を調整するのを支援するもので、薬効を向上させ、副作用を減らし、個別化医療戦略を強化することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の薬理遺伝学検査市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の薬理遺伝学検査市場の実績：規模と成長、2018～2023年
  • 世界の薬理遺伝学検査市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の薬理遺伝学検査市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 全ゲノム配列分析
  • 全エクソーム配列分析
  • 配列ベースのテスト
  • 単一遺伝子検査
  • 世界の薬理遺伝学検査市場：薬剤タイプ、実績と予測、2018～2023年、2023～2028年、2033年
  • 配合薬
  • 栄養補助食品
  • 娯楽用薬剤
  • ハーブサプリメント
  • ビタミン
  • 市販薬
  • 世界の薬理遺伝学検査市場：治療領域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 心臓病学
  • 消化器内科
  • 麻酔科
  • ゲノミクス
  • 内分泌学
  • 免疫学と過敏症
  • 皮膚科
  • 婦人科
  • 腫瘍学
  • その他
  • 世界の薬理遺伝学検査市場：流通チャネル別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院薬局
  • 小売薬局
  • 通信販売薬局
  • 顧客直結サービス
  • 世界の薬理遺伝学検査市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 医療提供者
  • 製薬とバイオテクノロジー企業
  • センターと学術機関
  • その他

第7章 地域別・国別分析

  • 世界の薬理遺伝学検査市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の薬理遺伝学検査市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 薬理遺伝学検査市場：競合情勢
  • 薬理遺伝学検査市場：企業プロファイル
    • CVS Health Corporation
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics Incorporated
    • Eurofins Scientific Inc.
    • Bio-Rad Laboratories

第31章 その他の大手企業と革新的企業

  • Precision Medicine Advsiors
  • Azenta Life Sciences
  • Fulgent Genetics
  • Pacific Biosciences of California Inc.
  • Castle Biosciences
  • 23andMe Holding Co.
  • Helix Inc.
  • Genomind Inc.
  • MD Labs
  • Sonic Genetics
  • AutoGenomics Inc.
  • LabClinics SA
  • Gene By Gene Ltd.
  • Xcode Life Sciences
  • YouScript

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20313

Pharmacogenetic testing is a specialized form of genetic testing that evaluates how an individual's genetic profile affects their response to specific medications, facilitating the customization of drug treatments to enhance efficacy and minimize side effects. This personalized approach significantly improves patient care by aligning therapies with genetic characteristics. It finds extensive application in areas such as oncology, psychology, and cardiology.

The primary types of pharmacogenetic testing include whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing is a thorough method that analyzes the entire genome of an individual, sequencing all DNA in a single test to provide a comprehensive view of genetic information. The scope of drugs assessed includes prescription medications, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter products across various therapeutic areas, such as cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and others. These products are distributed through hospital pharmacies, retail pharmacies, mail-order services, and direct-to-consumer channels, serving diverse end users including healthcare providers, pharmaceutical and biotechnology companies, research centers, and academic institutions.

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides pharmacogenetic testing market statistics, including pharmacogenetic testing industry global market size, regional shares, competitors with a pharmacogenetic testing market share, detailed pharmacogenetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. This pharmacogenetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $10.68 billion in 2023 to $12.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth observed during the historical period can be attributed to several factors, including enhanced overall drug efficacy, a rising adoption of personalized medicine, an increasing need for precision diagnostics, a heightened focus on pharmacogenetic testing, and growing medical expenditures.

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $22.28 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The anticipated growth during the forecast period can be attributed to several factors, including increased research and development in biotechnology and healthcare, rising healthcare expenditures, a growing prevalence of chronic diseases, enhanced accessibility to healthcare services, and the rise of telemedicine and digital health solutions. Key trends expected to shape this period include the expansion of pharmacogenetic testing, advancements in genomic technologies, ongoing technological innovations, improvements in companion diagnostics, and the development of novel diagnostic tests.

The rising demand for personalized medicine is anticipated to drive growth in the pharmacogenetic testing market in the foreseeable future. Also referred to as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments to align with the individual characteristics of each patient. The growing focus on personalized medicine is influenced by multiple factors, including improved treatment outcomes, an emphasis on prevention and early detection, and enhanced cost-effectiveness. Pharmacogenetic testing plays a crucial role in personalized medicine by examining an individual's genetic makeup to predict their response to specific medications. This allows healthcare providers to customize treatments based on genetic factors, optimizing drug efficacy and minimizing adverse effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the pharmacogenetic testing market.

Leading companies in the pharmacogenetics testing sector are advancing their offerings with cutting-edge pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to establish a competitive edge. Prescription-based pharmacogenetic testing involves genetic tests specifically ordered or prescribed by healthcare providers to analyze a patient's genetic profile prior to medication prescriptions. For example, in May 2023, UCSF, a US-based healthcare organization, introduced its pharmacogenomics testing service aimed at enhancing the precision of medical treatments. This service assists healthcare providers in tailoring drug therapies according to an individual's genetic profile, with the objective of improving drug efficacy, reducing adverse reactions, and bolstering personalized medicine strategies.

In May 2023, HealthOme, a US-based company specializing in advanced genetic testing and personalized medicine solutions, acquired Kailos Genetics for an undisclosed sum. This acquisition aims to strengthen HealthOme's genetic testing and personalized medicine capabilities by integrating Kailos Genetics' advanced genomic technologies and expertise. Kailos Genetics is a US-based firm that offers comprehensive pharmacogenetic testing services through its Inspexion platform.

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacogenetic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacogenetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Whole Genome Sequencing; Whole Exome Sequencing; Array-Based Tests; Single Gene Tests
  • 2) Drug Type: Prescription Drugs; Nutraceuticals; Recreational Drugs; Herbal Supplements; Vitamins; Over-The-Counter Medications
  • 3) Therapeutic Area: Cardiology; Gastroenterology; Anesthesiology; Genomics; Endocrinology; Immunology And Hypersensitivity; Dermatology; Gynecology; Oncology; Other Therapeutic Areas
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Mail-Order Pharmacies; Direct-to-Customer Services
  • 5) By End User: Healthcare Providers; Pharmaceutical And Biotechnology Companies; Centers And Academic Institutes; Other End Users
  • Companies Mentioned: CVS Health Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Eurofins Scientific Inc.; Bio-Rad Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacogenetic Testing Market Characteristics

3. Pharmacogenetic Testing Market Trends And Strategies

4. Pharmacogenetic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmacogenetic Testing Market Size and Growth

  • 5.1. Global Pharmacogenetic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmacogenetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacogenetic Testing Market Segmentation

  • 6.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Array-Based Tests
  • Single Gene Tests
  • 6.2. Global Pharmacogenetic Testing Market, Segmentation Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription Drugs
  • Nutraceuticals
  • Recreational Drugs
  • Herbal Supplements
  • Vitamins
  • Over-The-Counter Medications
  • 6.3. Global Pharmacogenetic Testing Market, Segmentation Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiology
  • Gastroenterology
  • Anesthesiology
  • Genomics
  • Endocrinology
  • Immunology And Hypersensitivity
  • Dermatology
  • Gynecology
  • Oncology
  • Other Therapeutic Areas
  • 6.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacies
  • Mail-Order Pharmacies
  • Direct-to-Customer Services
  • 6.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Healthcare Providers
  • Pharmaceutical And Biotechnology Companies
  • Centers And Academic Institutes
  • Other End Users

7. Pharmacogenetic Testing Market Regional And Country Analysis

  • 7.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacogenetic Testing Market

  • 8.1. Asia-Pacific Pharmacogenetic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacogenetic Testing Market

  • 9.1. China Pharmacogenetic Testing Market Overview
  • 9.2. China Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacogenetic Testing Market

  • 10.1. India Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacogenetic Testing Market

  • 11.1. Japan Pharmacogenetic Testing Market Overview
  • 11.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacogenetic Testing Market

  • 12.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacogenetic Testing Market

  • 13.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacogenetic Testing Market

  • 14.1. South Korea Pharmacogenetic Testing Market Overview
  • 14.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacogenetic Testing Market

  • 15.1. Western Europe Pharmacogenetic Testing Market Overview
  • 15.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacogenetic Testing Market

  • 16.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacogenetic Testing Market

  • 17.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacogenetic Testing Market

  • 18.1. France Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacogenetic Testing Market

  • 19.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacogenetic Testing Market

  • 20.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacogenetic Testing Market

  • 21.1. Eastern Europe Pharmacogenetic Testing Market Overview
  • 21.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacogenetic Testing Market

  • 22.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacogenetic Testing Market

  • 23.1. North America Pharmacogenetic Testing Market Overview
  • 23.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacogenetic Testing Market

  • 24.1. USA Pharmacogenetic Testing Market Overview
  • 24.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacogenetic Testing Market

  • 25.1. Canada Pharmacogenetic Testing Market Overview
  • 25.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacogenetic Testing Market

  • 26.1. South America Pharmacogenetic Testing Market Overview
  • 26.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacogenetic Testing Market

  • 27.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacogenetic Testing Market

  • 28.1. Middle East Pharmacogenetic Testing Market Overview
  • 28.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacogenetic Testing Market

  • 29.1. Africa Pharmacogenetic Testing Market Overview
  • 29.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacogenetic Testing Market Competitive Landscape
  • 30.2. Pharmacogenetic Testing Market Company Profiles
    • 30.2.1. CVS Health Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Quest Diagnostics Incorporated
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bio-Rad Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmacogenetic Testing Market Other Major And Innovative Companies

  • 31.1. Precision Medicine Advsiors
  • 31.2. Azenta Life Sciences
  • 31.3. Fulgent Genetics
  • 31.4. Pacific Biosciences of California Inc.
  • 31.5. Castle Biosciences
  • 31.6. 23andMe Holding Co.
  • 31.7. Helix Inc.
  • 31.8. Genomind Inc.
  • 31.9. MD Labs
  • 31.10. Sonic Genetics
  • 31.11. AutoGenomics Inc.
  • 31.12. LabClinics SA
  • 31.13. Gene By Gene Ltd.
  • 31.14. Xcode Life Sciences
  • 31.15. YouScript

32. Global Pharmacogenetic Testing Market Competitive Benchmarking

33. Global Pharmacogenetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

35. Pharmacogenetic Testing Market Future Outlook and Potential Analysis

  • 35.1 Pharmacogenetic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmacogenetic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmacogenetic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer